Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC
Clinical trial NCT05134532 · UNKNOWN
Trial details
- NCT number
- NCT05134532
- Sponsor
- CHA University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-24
- Primary completion
- 2024-10-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.